Page 26 - Bharat Biotech

When will India finally have access to coronavirus vaccine?

India commands 40 per cent of global capacity for vaccines which is estimated at 5.7 billion doses

Top headlines: Q1 earnings shrink, telcos await SC verdict on AGR and more

From auto firms planning new launches for festive season, Rajnath Singh banning import of defence items to telcos awaiting SC response of AGR dues, here are the top ness of the day

Don't want to launch Covid vaccine under pressure, says Bharat Biotech CMD

Asserts safety and quality are important and that his firm will develop a vaccine that's affordable for all

Want to volunteer for a coronavirus vaccine trial? Things you should know

With the studies entering human trial phase, a critical requirement is to select volunteers who are willing to participate

Hyderabad's NIMS begins human trials of coronavirus vaccine Covaxin

The healthy volunteers, who were administered the first dose of the vaccine in the morning, were stable.

Covid-19: AIIMS to start human clinical trial of Covaxin from Monday

Covaxin is being tested in 12 places, according to the Indian Council for Medical Research.

Bharat Biotech starts human trials of Covid-19 vaccine in PGI Rohtak

Bharat Biotech got the country's drug regulator's approval to start clinical trials of its anti-Corona vaccine Covaxin recently

Indian pharma can produce Covid-19 vaccines for entire world: Bill Gates

India's challenge immense in coronavirus crisis immense because of its large population, says billionaire philanthropist

Why vaccines can't be launched overnight

Under normal circumstances, the development of new vaccines and treatments could take 10-20 years

Covid-19 vaccine: Over to clinical sites to set a deadline for Covaxin

Sites may end with varying timelines based on site initiation visit by Bharat Biotech

With no Aug 15 deadline, Covaxin clinical trial timelines get site-specific

Sites may end with varying timeline based on site initiation visit by Bharat Biotech

ICMR's deadline for Covid-19 vaccine launch an 'unscientific gaffe': Sibal

Bharat Biotech had recently received a nod for a clinical trial of its vaccine - Covaxin

Covaxin, ZyCov-D trails mark 'beginning of the end' of Covid-19: Scientist

The article has been published on the websites of the Press Information Bureau (PIB) and the Vigyan Prasar, which is a body under the ministry

Human trial stage of vaccine 'marks beginning of the end' of Covid-19: Govt

Along with the two Indian efforts, the world over, 11 out of 140 vaccine candidates have entered the human trial phase

Covid-19 crisis: Race to develop vaccine gets a booster as field widens

On Thursday, CDSCO also approved Zydus Cadila's plasmid DNA vaccine candidate ZyCoV-D, developed at its Vaccine Technology Centre in Ahmedabad.

ICMR-Bharat Biotech Covid-19 vaccine trial results to be released by Aug 15

A total of 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered the topmost priority projects which are being monitored by the government

Nearly 21,000 cases in a day in India: Coronavirus updates and highlights

India reported nearly 21,000 coronavirus cases in the last 24 hours, taking the total to 625,544, according to the Health Ministry.

Covid-19 crisis: Health care workers may get vaccine after phase 2 trials

Indigenously developed Bharat Biotech's vaccine candidate Covaxin is entering human trials on Wednesday.

Covid-19 crisis: Bharat Biotech's vaccine gets nod for human trials

The SARS-CoV-2 strain was isolated at National Institute of Virology (Pune), an institute under the ICMR, and transferred to Bharat Biotech.

Shot of Hope: Equal access a hurdle after race to coronavirus vaccine

The second of a two-part series examines challenges linked to IPR and monopoly once Covid-19 vaccine is created